Editorial: metabolic adaptation of colonic microbiota to galactooligosaccharides - good news for prebiotics in irritable bowel syndrome?
H M Staudacher,
S R Cox
Other
Alimentary pharmacology & therapeutics
2017
PubMed
DOI
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'pmid\u003D28256083';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
Kısaca
A randomised clinical trial: exploratory phase 2 study of ONO-2952 in diarrhoea-predominant irritable bowel syndrome and safety, tolerability, and pharmacokinetic profile of the novel translocator protein 18 kDa antagonist onO- 2952 in healthy volunteers.
Used In Evidence Reviews
Similar Papers
Alimentary pharmacology & therapeutics · 2006
Review article: prebiotics in the gastrointestinal tract.
629 citations
The Journal of nutrition · 2012
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.
558 citations
Gastroenterology · 2020
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
290 citations
Open Access
Journal of gastroenterology and hepatology · 2017
Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.
255 citations
Open Access
World journal of gastroenterology · 2016
Diet and nutritional factors in inflammatory bowel diseases.
238 citations
Open Access
Journal of gastroenterology and hepatology · 2017
FODMAPs: food composition, defining cutoff values and international application.
181 citations
Open Access